Cargando…
Circulating Long Noncoding RNAs Act as Diagnostic Biomarkers in Non-Small Cell Lung Cancer
Identification of novel effective early diagnostic biomarkers may provide alternative strategies to reduce the mortality for non-small cell lung cancer (NSCLC) patients. Circulating long non-coding RNAs (lncRNAs) have emerged as a new class of promising cancer biomarkers. Our study aimed to identify...
Autores principales: | Yuan, Shuai, Xiang, Ying, Guo, Xiaoping, Zhang, Yao, Li, Chengying, Xie, Weijia, Wu, Na, Wu, Long, Cai, Tongjian, Ma, Xiangyu, Yu, Zubin, Bai, Li, Li, Yafei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793881/ https://www.ncbi.nlm.nih.gov/pubmed/33425713 http://dx.doi.org/10.3389/fonc.2020.537120 |
Ejemplares similares
-
Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer
por: Liu, Qingyun, et al.
Publicado: (2016) -
Single‐nucleotide polymorphism rs4142441 and MYC co‐modulated long non‐coding RNA OSER1‐AS1 suppresses non‐small cell lung cancer by sequestering ELAVL1
por: Xie, Weijia, et al.
Publicado: (2021) -
Hypoxia‐sensitive LINC01436 is regulated by E2F6 and acts as an oncogene by targeting miR‐30a‐3p in non‐small cell lung cancer
por: Yuan, Shuai, et al.
Publicado: (2019) -
The role of noncoding RNAs in cancer lipid metabolism
por: Wang, Ye, et al.
Publicado: (2022) -
Diagnostic value of tumor-associated autoantibodies panel in combination with traditional tumor markers for lung cancer
por: Xu, Yu, et al.
Publicado: (2023)